[1]
|
[1] M. G. Carlsson, H. Ryd and N. H. Sternby, “A Case of Human Infection with Pasteurellapseudotuberculosis X,” Acta Pathologica Microbiologica Scandinavica, Vol. 62, 1964, pp. 128-132.
|
[2]
|
[2] B. Nilehn and B. Sj?str?m, “Studies on Yersinia Enterocolitica. Occurence in Various Groups of Acute Abdominal Disease,” Acta Pathologica Microbiologica Scandinavica, Vol. 71, No. 4, 1967, pp. 612-628.
doi:10.1111/j.1699-0463.1967.tb05182.x
|
[3]
|
[3] B. Arvastson, K. Damgaard and S. Winblad, “Clinical Symptoms of Infection with Yersinia Enterocolitica,” Scandinavian Journal of Infectious Diseases, Vol. 3, No. 1, 1971, pp. 37-40.
|
[4]
|
[4] P. Ahvonen, “Human Yersiniosis in Finland, II. Clinical Features,” Annals of Clinical Research, Vol. 4, No. 1, 1972, pp. 39-48.
|
[5]
|
[5] A. Saebo and J. Lassen, “A Survey of Acute and Chronic Disease Associated with Yersinia Enterocolitica Infection. A Norwegian 10-year Follow-up Study on 458 Hospitalized Patients,” Scandinavian Journal of Infectious Diseases, Vol. 23, No. 5, 1991, pp. 517-527.
doi:10.3109/00365549109105172
|
[6]
|
[6] K. Aho, P. Ahvonen, A. Lassus, K. Sievers and A. Tiilikainen, “HL-A27 in Reactive Arthritis. A Study of Yersinia Arthritis and Reiter’s Disease,” Arthritis & Rheumatism, Vol. 17, No. 5, 1974, pp. 521-526.
doi:10.1002/art.1780170505
|
[7]
|
[7] M. Leirisalo, G. Skylv, M. Kousa, L. M. Voipo-Pulkki , H. Souranta, M. Nissila, et al., “Follow-up Study on Patients with Reiter’s Disease and Reactive Arthritis, with Special Reference to HLA-B27,” Arthritis & Rheumatism, Vol. 25, No. 3, 1982, pp. 249-259.
doi:10.1002/art.1780250302
|
[8]
|
[8] M. Friedberg, T. Denneberg, C. Brun, J. H. Larsen, S. Larsen, “Glomerulonephritis in Infection with Yersinia Enterocolitica O-serotype 3. II. The Incidence and Immunological Features of Yersinia Infection in a Consecutive Glomerulonephritis Population,” Acta Medica Scandinavica, Vol. 209, No. 1-6, 1981, pp. 103-110. doi:10.1111/j.0954-6820.1981.tb11560.x
|
[9]
|
[9] K. A. Sotaniemi, “Neurologic Complications Associated with Yersiniosis,” Neurology, Vol. 33, No. 1, 1983, pp. 95-97.
|
[10]
|
[10] A. Saebo, “Liver Affection Associated with Yersinia Enterocolitica Infection,” Acta Chirurgica Scandinavica, Vol. 143, No. 7-8, 1977, pp. 445-450.
|
[11]
|
[11] A. Saebo, E. Vik, O. J. Lange and L. Matuszkiewicz, “Inflammatory Bowel Disease Associated with Yersinia Enterocolitica O:3 Infection,” European Journal of Internal Medicine, Vol. 16, No. 3, 2005, pp. 176-182. doi:10.1016/j.ejim.2004.11.008
|
[12]
|
[12] M. Leirisalo-Repo and H. Souranta, “Ten-Year Follow-up Study of Patients with Yersinia Arthritis,” Arthritis & Rheumatism, Vol. 31, No. 4, 1988, pp. 533-537.
doi:10.1002/art.1780310410
|
[13]
|
[13] H. Lindholm and R. Visakorpi, “Late Complications after a Yersinia Enterocolitica Epidemic: A Follow up Study”. Annals of the Rheumatic Diseases, Vol. 50, No. 10, 1991, pp. 694-696. doi:10.1136/ard.50.10.694
|
[14]
|
[14] J. A. A. Hoogkamp-Korstanje, J. de Koning and J. Heesemann, “Persistence of Yersinia Enterocolitica in Man,” Infection, Vol. 16, No. 2, 1988, pp. 81-85.
doi:10.1007/BF01644307
|
[15]
|
[15] L. Vold and K. Nygard, “Yersiniosis in Norway 2002,” MSIS-rapport, (In Norwegian), Communicable Disease Report, Norwegian Institute of Public Health, Oslo, Vol. 31, 2003, pp. 40.
|
[16]
|
[16] F. Kallinowski, A. Wassmer, M. A. Hoffmann, D. Harmsen, J. Heesemann, H. Karch, et al., “Prevalence of Enteropatogenic Bacteria in Surgically Treated Chronic Inflammatory Bowel Disease,” Heptogastroenterology, Vol. 45, No. 23, 1998, pp. 1552-1558.
|
[17]
|
[17] J. A. Hoogkamp-Korstanje, J. de Koning, J. Heesemann , J. J. Festen, P. M. Houtman and P. L. van Oyen, “Influence of Antibiotics on IgA and IgG Response and Persistence of Yersinia Enterocolitica in Patients with Yersinia-Associated Spondylarthropathy,” Infection, Vol. 20, No. 2, 1992, pp. 53-57. doi:10.1007/BF01711062
|
[18]
|
[18] B. E. Wenzel, J. Heesemann, A. Heufelder, T. F. Franke S. Grammerstorf, R. Stemerowicz, et al., “Ente- ropathogenic Yersinia Enterocolitica and Organ- Specific Autoimmune Disease in Man,” Contrib Microbiol Immunol, Vol. 12, 1991, pp. 80-88.
|
[19]
|
[19] A. Saebo, G. Kapperud, J. Lassen and J. O. Waage “Prevalence of Antibodies to Yersinia Enterocolitica O:3 among Norwegian Military Recruits: Association with Risk Factors and Clinical Manifestations,” European Journal of Epidemiology, Vol. 10, No. 6, 1994, pp. 749-755. doi:10.1007/BF01719293
|
[20]
|
[20] A. Saebo and J. Lassen, “Acute and chronic Gastrointestinal Manifestations Associated with Yersinia Infection. A Norwegian 10-year Follow-up Study on 458 Hospitalized Patients,” Annals of Surgery, Vol. 215, No. 3, 1992, pp. 250-255.
doi:10.1097/00000658-199203000-00009
|
[21]
|
[21] G. Vantrappen, E. Ponette, K.Geboes, P. Bertrand, “Yersinia Enteritis and Enterocolitis: Gastroenterological Aspects,” Gastroenterology, Vol. 72, No. 2, 1977, pp. 220-227.
|
[22]
|
[22] A. Saebo, “The Yersinia Enterocolitica Infection in Acute Abdominal Surgery: A Clinical Study with a 5 Year Follow-up Period,” Annals of Surgery, Vol. 198, No. 6, 1983, pp. 760-765.
doi:10.1097/00000658-198312000-00015
|
[23]
|
[23] K. Granfors, M. Viljanen, A. Tiilikainen, A. Toivanen “Persistence of IgM, IgG, and IgA antibodies to Yersinia in Yersinia arthritis,” Journal of Infectious Diseases, Vol. 141, No. 4, 1980, pp. 424-249.
doi:10.1093/infdis/141.4.424
|
[24]
|
[24] J. H. Larsen, S. H. Hartzen and M. Parm, “The Determination of Specific IgA-Antibodies to Yersinia Enterocolitica and their Role in Enteric Infections and their Complications,” Acta Pathologica Microbiologica Scandinavica Series B: Microbiology, Vol. 93, No. 1-6, 1985, pp. 331-339.
|
[25]
|
[25] J. A. A. Hoogkamp-Korstanje, H. Moesker, G. A. W. Bruyn, “Ciprofloxacin v Placebo for Treatment of Yersinia Enterocolitica Triggered Reactive Arthritis,” Annals of the Rheumatic Diseases, Vol. 59, No. 11, 2000, pp. 914-917. doi:10.1136/ard.59.11.914
|